Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat - PubMed (original) (raw)
Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat
C S Lee et al. Neuroscience. 1996 Jun.
Abstract
6-Hydroxydopamine-induced nerve terminal lesion of the nigrostriatal system may provide a partial lesion model of Parkinson's disease useful for the assessment of neuroprotective treatments and behavioral recovery after therapeutic intervention. The aim of the present study was to assess the retrograde degenerative changes in the dopaminergic neurons of the substantia nigra and the associated behavioral and neurochemical consequences of intrastriatal injections of 6-hydroxydopamine in young adult rats. Four groups of rats were stereotaxically injected in the right striatum with graded doses of 6-hydroxydopamine ranging from 0 to 20 mu g. Structural and functional deficits were quantified by tyrosine hydroxylase-immunoreactive nigral cell numbers, striatal dopamine content, skilled paw use, and drug-induced rotation. The results show that striatal 6-hydroxydopamine lesions produce dose-dependent decreases in striatal dopamine levels and tyrosine hydroxylase-immunoreactive cell numbers in the ipsilateral substantia nigra, accompanied by a significant long-lasting atrophy of the remaining dopaminergic neurons. Paw reaching test scores on the side contralateral to the lesion were non-linearly correlated with dopaminergic neuronal cell loss and exhibited a clear symptomatic threshold such that impaired paw use appeared only after >50% loss of nigral dopamine neurons or a reduction of 60-80% of striatal dopamine levels. The behavioral, cellular, and neurochemical effects of the nerve terminal lesion thus bear some resemblance to the early stages of Parkinson's disease, where the severity of motor impairment is correlated with the loss of dopamine in the striatum and dopaminergic neuronal loss in the substantia nigra. Rats with intrastriatal 6-hydroxydopamine lesions thus provide a model of progressive dopamine neuron degeneration useful not only for the exploration of neuroprotective therapeutic intervention but also for the study of mechanisms of functional and structural recovery after subtotal damage of the nigrostriatal dopamine system.
Similar articles
- Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae.
Schwarting RK, Huston JP. Schwarting RK, et al. Prog Neurobiol. 1996 Jun;49(3):215-66. doi: 10.1016/s0301-0082(96)00015-9. Prog Neurobiol. 1996. PMID: 8878304 Review. - Neuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease.
Piallat B, Benazzouz A, Benabid AL. Piallat B, et al. J Neural Transm Suppl. 1999;55:71-7. doi: 10.1007/978-3-7091-6369-6_7. J Neural Transm Suppl. 1999. PMID: 10335494 Review.
Cited by
- Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
Cerri S, Greco R, Levandis G, Ghezzi C, Mangione AS, Fuzzati-Armentero MT, Bonizzi A, Avanzini MA, Maccario R, Blandini F. Cerri S, et al. Stem Cells Transl Med. 2015 Sep;4(9):1073-85. doi: 10.5966/sctm.2015-0023. Epub 2015 Jul 21. Stem Cells Transl Med. 2015. PMID: 26198165 Free PMC article. - A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study.
Healy-Stoffel M, Ahmad SO, Stanford JA, Levant B. Healy-Stoffel M, et al. J Neurosci Methods. 2012 Sep 30;210(2):187-94. doi: 10.1016/j.jneumeth.2012.07.013. Epub 2012 Jul 28. J Neurosci Methods. 2012. PMID: 22850559 Free PMC article. - Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
Hennis MR, Marvin MA, Taylor CM 2nd, Goldberg MS. Hennis MR, et al. Neurobiol Dis. 2014 Feb;62:113-23. doi: 10.1016/j.nbd.2013.09.009. Epub 2013 Sep 26. Neurobiol Dis. 2014. PMID: 24075852 Free PMC article. - Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson's Disease.
Jewett M, Jimenez-Ferrer I, Swanberg M. Jewett M, et al. Brain Sci. 2017 Jun 26;7(7):73. doi: 10.3390/brainsci7070073. Brain Sci. 2017. PMID: 28672859 Free PMC article. - Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson's Disease.
Prasad EM, Hung SY. Prasad EM, et al. Antioxidants (Basel). 2020 Oct 16;9(10):1007. doi: 10.3390/antiox9101007. Antioxidants (Basel). 2020. PMID: 33081318 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials